Regenerative medicine company Advanced BioHealing is now part of Shire (NASDAQ:SHPGY), but before it was acquired last May, the Westport, Connecticut company was hours from pulling the trigger on an ...

Acquisition includes U.S.-marketed bioengineered skin substitute for diabetic foot ulcers. Shire is paying $750 million in cash to buy Advanced BioHealing as the foundation for establishing a ...

Shire Plc, the Irish maker of treatments for attention-deficit disorder, last week said it agreed to buy closely held Westport-based Advanced BioHealing Inc. for $750 million in cash, a day before the ...

Advanced BioHealing, the San Diego maker of the Dermagraft skin patch, has been sold to Irish pharmaceutical company Shire for $750 million as executives quickly scuttled plans to take the business ...

Shire is making a move into regenerative medicine and will acquire the USA's Advanced BioHealing for $750 million in cash. Shire is making a move into regenerative medicine and will acquire the USA’s ...

WESTPORT, Conn., Dec. 10, 2010 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine, today announced ...

Advanced BioHealing Raises $25.5 Million in Series C Financing LA JOLLA, Calif., Feb. 27, 2007 -- Advanced BioHealing, Inc. (ABH) today announced that it has raised $25.5 million in a Series C round ...

WESTPORT, Conn.--(BUSINESS WIRE)--Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it will host four events focusing on the standard of ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. An ulcer treatment once discarded by Smith & Nephew has been bought by Shire, another FTSE 100 healthcare ...

Dublin, Ireland - May 17, 2011 - Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire Advanced BioHealing, Inc. * Creation of a new ...

LONDON—Shire PLC has agreed to buy U.S.-based regenerative drug maker Advanced BioHealing Inc. for $750 million in cash, in a deal that will add a new line of business for the U.K. specialty ...